CA2328331A1 - Composition comprenant de la l-carnitine ou un alcanoyl l-carnitine et nadh et/ou nadph - Google Patents
Composition comprenant de la l-carnitine ou un alcanoyl l-carnitine et nadh et/ou nadph Download PDFInfo
- Publication number
- CA2328331A1 CA2328331A1 CA002328331A CA2328331A CA2328331A1 CA 2328331 A1 CA2328331 A1 CA 2328331A1 CA 002328331 A CA002328331 A CA 002328331A CA 2328331 A CA2328331 A CA 2328331A CA 2328331 A1 CA2328331 A1 CA 2328331A1
- Authority
- CA
- Canada
- Prior art keywords
- carnitine
- nadh
- composition
- alkanoyl
- pharmacologically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Nutrition Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne une composition qui comprend de la L-carnitine ou un alcanoyl L-carnitine ou le sel pharmacologiquement acceptable de ces derniers et du NADH et/ou NADPH. Cette composition constitue un complément alimentaire pour les sujets pratiquant un exercice physique intense ou pour des sujets asthéniques, et comme médicament pour traiter le syndrome de fatigue chronique et la maladie de Parkinson.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM98A000238 | 1998-04-17 | ||
IT98RM000238A IT1299161B1 (it) | 1998-04-17 | 1998-04-17 | Composizione comprendente l-carnitina o un'alcanoil l-carnitina e nadh e/o nadph |
PCT/IT1999/000088 WO1999053921A1 (fr) | 1998-04-17 | 1999-04-14 | Composition comprenant de la l-carnitine ou un alcanoyl l-carnitine et nadh et/ou nadph |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2328331A1 true CA2328331A1 (fr) | 1999-10-28 |
Family
ID=11405812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002328331A Abandoned CA2328331A1 (fr) | 1998-04-17 | 1999-04-14 | Composition comprenant de la l-carnitine ou un alcanoyl l-carnitine et nadh et/ou nadph |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1071424A1 (fr) |
JP (1) | JP2002512191A (fr) |
KR (1) | KR20010042765A (fr) |
CN (1) | CN1299283A (fr) |
AU (1) | AU750645B2 (fr) |
BR (1) | BR9909712A (fr) |
CA (1) | CA2328331A1 (fr) |
EE (1) | EE200000601A (fr) |
HU (1) | HUP0101914A3 (fr) |
IL (1) | IL139014A0 (fr) |
IS (1) | IS5663A (fr) |
IT (1) | IT1299161B1 (fr) |
NO (1) | NO20005128L (fr) |
PL (1) | PL343482A1 (fr) |
SK (1) | SK15442000A3 (fr) |
TR (1) | TR200002894T2 (fr) |
WO (1) | WO1999053921A1 (fr) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8252309B2 (en) | 2000-04-04 | 2012-08-28 | Sigma-Tau Industrie Farmaceutiche Riunite Spa | Dietary supplement energy-providing to skeletal muscles |
DE10326822A1 (de) * | 2003-06-11 | 2005-01-05 | Herzpharma Vita-Check Diagnosegeräte GmbH | Mittel zur Nahrungsergänzung, dieses Mittel enthaltende pharmazeutische Präparate und Verwendungen des Mittels |
MX2009012042A (es) * | 2007-05-11 | 2009-12-01 | Sigma Tau Ind Farmaceuti | Gel util para el suministro de ingredientes activos cosmeticos. |
WO2011022786A1 (fr) * | 2009-08-31 | 2011-03-03 | Pharmaqest Pty Ltd | Procédés de diagnostic et de traitement du syndrome de fatigue chronique |
CN104306390A (zh) * | 2014-10-23 | 2015-01-28 | 苏州人本药业有限公司 | 还原型辅酶ⅱ的用途 |
CN104840479A (zh) * | 2015-02-17 | 2015-08-19 | 苏州人本药业有限公司 | Nadph在制备治疗心脏疾病药物中的应用 |
ES2786774B2 (es) * | 2017-12-22 | 2022-03-04 | Bontac Bio Eng Shenzhen Co Ltd | Composición para compuesto de coenzima NADH, preparación y aplicación del mismo. |
PL3755160T3 (pl) | 2018-04-20 | 2022-02-14 | Pacotrade Ag | Urządzenie do rozdrabniania głęboko mrożonych środków spożywczych przygotowanych w formie bloku |
CN109170907A (zh) * | 2018-08-30 | 2019-01-11 | 泓博元生命科技(深圳)有限公司 | 一种含有nmn的组合物、应用及运动饮料的制备方法 |
CN109105702A (zh) * | 2018-08-30 | 2019-01-01 | 泓博元生命科技(深圳)有限公司 | 一种含有nadh的组合物、应用及能量补充剂的制备方法 |
CA3115743A1 (fr) * | 2018-10-10 | 2020-04-16 | So Ngor Sally LEUNG | Composition de produit de sante permettant de compenser un deficit, son procede de preparation et son application |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1054698A (fr) * | 1964-12-04 | |||
US5292538A (en) * | 1992-07-22 | 1994-03-08 | Metagenics, Inc. | Improved sustained energy and anabolic composition and method of making |
DE4335454A1 (de) * | 1993-10-19 | 1995-04-20 | Schleicher Peter | Geriatrikum |
JPH09110708A (ja) * | 1995-08-11 | 1997-04-28 | Taisho Pharmaceut Co Ltd | 滋養強壮用生薬配合製剤 |
JPH0959161A (ja) * | 1995-08-23 | 1997-03-04 | Taisho Pharmaceut Co Ltd | 疲労改善用組成物 |
IT1277953B1 (it) * | 1995-12-21 | 1997-11-12 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per |
IT1283951B1 (it) * | 1996-03-15 | 1998-05-07 | Mendes Srl | Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di |
US5712259A (en) * | 1996-04-22 | 1998-01-27 | Birkmayer Pharmaceuticals | NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome |
US6077828A (en) * | 1996-04-25 | 2000-06-20 | Abbott Laboratories | Method for the prevention and treatment of cachexia and anorexia |
JPH10175856A (ja) * | 1996-10-14 | 1998-06-30 | Taisho Pharmaceut Co Ltd | 疲労改善剤 |
-
1998
- 1998-04-17 IT IT98RM000238A patent/IT1299161B1/it active IP Right Grant
-
1999
- 1999-04-14 SK SK1544-2000A patent/SK15442000A3/sk unknown
- 1999-04-14 TR TR2000/02894T patent/TR200002894T2/xx unknown
- 1999-04-14 JP JP2000544325A patent/JP2002512191A/ja active Pending
- 1999-04-14 CA CA002328331A patent/CA2328331A1/fr not_active Abandoned
- 1999-04-14 PL PL99343482A patent/PL343482A1/xx not_active Application Discontinuation
- 1999-04-14 BR BR9909712-5A patent/BR9909712A/pt not_active IP Right Cessation
- 1999-04-14 HU HU0101914A patent/HUP0101914A3/hu unknown
- 1999-04-14 IL IL13901499A patent/IL139014A0/xx unknown
- 1999-04-14 CN CN99805644A patent/CN1299283A/zh active Pending
- 1999-04-14 KR KR1020007011499A patent/KR20010042765A/ko not_active Application Discontinuation
- 1999-04-14 WO PCT/IT1999/000088 patent/WO1999053921A1/fr not_active Application Discontinuation
- 1999-04-14 EP EP99916039A patent/EP1071424A1/fr not_active Withdrawn
- 1999-04-14 AU AU34428/99A patent/AU750645B2/en not_active Ceased
- 1999-04-14 EE EEP200000601A patent/EE200000601A/xx unknown
-
2000
- 2000-10-12 NO NO20005128A patent/NO20005128L/no not_active Application Discontinuation
- 2000-10-13 IS IS5663A patent/IS5663A/is unknown
Also Published As
Publication number | Publication date |
---|---|
EE200000601A (et) | 2002-04-15 |
IS5663A (is) | 2000-10-13 |
KR20010042765A (ko) | 2001-05-25 |
TR200002894T2 (tr) | 2001-01-22 |
WO1999053921A1 (fr) | 1999-10-28 |
NO20005128L (no) | 2000-12-18 |
SK15442000A3 (sk) | 2001-06-11 |
IT1299161B1 (it) | 2000-02-29 |
HUP0101914A3 (en) | 2002-12-28 |
BR9909712A (pt) | 2000-12-26 |
NO20005128D0 (no) | 2000-10-12 |
JP2002512191A (ja) | 2002-04-23 |
IL139014A0 (en) | 2001-11-25 |
HUP0101914A2 (hu) | 2002-03-28 |
ITRM980238A1 (it) | 1999-10-17 |
ITRM980238A0 (it) | 1998-04-17 |
PL343482A1 (en) | 2001-08-27 |
AU750645B2 (en) | 2002-07-25 |
CN1299283A (zh) | 2001-06-13 |
AU3442899A (en) | 1999-11-08 |
EP1071424A1 (fr) | 2001-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0973415B1 (fr) | Complement nutritionnel destine a faciliter l'adaptation de muscles squelettiques lors d'exercices eprouvants et a lutter contre le surmenage chez des individus astheniques | |
Abraham et al. | Management of fibromyalgia: rationale for the use of magnesium and malic acid | |
CA2334415C (fr) | Compositions permettant d'accroitre l'energie in vivo | |
US20120053240A1 (en) | Method of Administering beta-hydroxy-beta-methylbutyrate (HMB) | |
US8747906B2 (en) | Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose | |
US6534480B2 (en) | Compositions for increasing energy in vivo | |
AU750645B2 (en) | Composition comprising L-carnitine or an alkanoyl L-carnitine and NADH and/or NADPH | |
US20050249713A1 (en) | Dietary supplement energy-providing to skeletal muscles and protecting the cardiovascular tract | |
Maher | Effects of nutrients on brain function | |
MXPA00009983A (en) | Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph | |
ES2269355T3 (es) | Composicion para la prevencion y/o tratamiento de enfermedades vasculares, constituida por l-carnitina de propionil y coencima q10. | |
JP2008508312A (ja) | 筋肉エネルギー産生増強目的のためのメチルピルベートの用途 | |
CZ20003831A3 (cs) | Přípravek obsahující L-karnitin nebo alkanoyl Lkarnitinu a NADH a/nebo NADPH | |
WO2023156275A1 (fr) | Composition pharmaceutique et médicament comprenant du l-tryptophane, du l-5-hydroxytryptophane et un inhibiteur de dégradation périphérique | |
MXPA99008999A (en) | Nutritional supplement for facilitating skeletal muscle adaptation to strenuous exercise and counteracting defatigation in asthenic individuals | |
CZ347999A3 (cs) | Doplňková výživa pro snazší adaptaci kosterního svalstva vyčerpaného zatěžujícími výkony a paralyzování únavy asthenických jedinců |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |